My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 204

    1.

    Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4).

    Herder C, Kolb H, Koenig W, Haastert B, Müller-Scholze S, Rathmann W, Holle R, Thorand B, Wichmann HE.

    Diabetes Care. 2006 Feb;29(2):368-71.PMID: 16443889 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4).

    Herder C, Haastert B, Müller-Scholze S, Koenig W, Thorand B, Holle R, Wichmann HE, Scherbaum WA, Martin S, Kolb H.

    Diabetes. 2005 Dec;54 Suppl 2:S11-7.PMID: 16306328 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors.

    Müller S, Martin S, Koenig W, Hanifi-Moghaddam P, Rathmann W, Haastert B, Giani G, Illig T, Thorand B, Kolb H.

    Diabetologia. 2002 Jun;45(6):805-12. Epub 2002 May 8.PMID: 12107724 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002.

    Herder C, Klopp N, Baumert J, Müller M, Khuseyinova N, Meisinger C, Martin S, Illig T, Koenig W, Thorand B.

    Diabetologia. 2008 Feb;51(2):276-84. Epub 2007 Aug 22.PMID: 17712545 [PubMed - indexed for MEDLINE]Related articles

    5.

    Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.

    Thorand B, Baumert J, Kolb H, Meisinger C, Chambless L, Koenig W, Herder C.

    Diabetes Care. 2007 Apr;30(4):854-60.PMID: 17392546 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Comparison of serum concentrations of C-reactive protein, TNF-alpha, and interleukin 6 between elderly Korean women with normal and impaired glucose tolerance.

    Choi KM, Lee J, Lee KW, Seo JA, Oh JH, Kim SG, Kim NH, Choi DS, Baik SH.

    Diabetes Res Clin Pract. 2004 May;64(2):99-106.PMID: 15063602 [PubMed - indexed for MEDLINE]Related articles

    7.

    Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984-2002.

    Herder C, Baumert J, Thorand B, Koenig W, de Jager W, Meisinger C, Illig T, Martin S, Kolb H.

    Diabetologia. 2006 May;49(5):921-9. Epub 2006 Mar 11.PMID: 16532324 [PubMed - indexed for MEDLINE]Related articles

    8.

    Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes: results from the Finnish Diabetes Prevention Study.

    Herder C, Peltonen M, Koenig W, Kräft I, Müller-Scholze S, Martin S, Lakka T, Ilanne-Parikka P, Eriksson JG, Hämäläinen H, Keinänen-Kiukaanniemi S, Valle TT, Uusitupa M, Lindström J, Kolb H, Tuomilehto J.

    Diabetes. 2006 Aug;55(8):2340-6.PMID: 16873699 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Systemic monocyte chemoattractant protein-1 concentrations are independent of type 2 diabetes or parameters of obesity: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4).

    Herder C, Müller-Scholze S, Rating P, Koenig W, Thorand B, Haastert B, Holle R, Illig T, Rathmann W, Seissler J, Wichmann HE, Kolb H.

    Eur J Endocrinol. 2006 Feb;154(2):311-7.PMID: 16452546 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Relation of C-reactive protein to features of the metabolic syndrome in normal glucose tolerant, impaired glucose tolerant, and newly diagnosed type 2 diabetic subjects.

    Guerrero-Romero F, Rodríguez-Morán M.

    Diabetes Metab. 2003 Feb;29(1):65-71.PMID: 12629450 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Hypoadiponectinemia and proinflammatory state: two sides of the same coin?: results from the Cooperative Health Research in the Region of Augsburg Survey 4 (KORA S4).

    Herder C, Hauner H, Haastert B, Röhrig K, Koenig W, Kolb H, Müller-Scholze S, Thorand B, Holle R, Rathmann W.

    Diabetes Care. 2006 Jul;29(7):1626-31.PMID: 16801589 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    C-reactive protein predicts the deterioration of glycemia in chinese subjects with impaired glucose tolerance.

    Tan KC, Wat NM, Tam SC, Janus ED, Lam TH, Lam KS.

    Diabetes Care. 2003 Aug;26(8):2323-8.PMID: 12882856 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Serum progranulin concentrations may be associated with macrophage infiltration into omental adipose tissue.

    Youn BS, Bang SI, Klöting N, Park JW, Lee N, Oh JE, Pi KB, Lee TH, Ruschke K, Fasshauer M, Stumvoll M, Blüher M.

    Diabetes. 2009 Mar;58(3):627-36. Epub 2008 Dec 3.PMID: 19056610 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg Study, 1984-2002.

    Thorand B, Kolb H, Baumert J, Koenig W, Chambless L, Meisinger C, Illig T, Martin S, Herder C.

    Diabetes. 2005 Oct;54(10):2932-8.PMID: 16186395 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Inflammation and type 2 diabetes: results from KORA Augsburg.

    Herder C, Illig T, Rathmann W, Martin S, Haastert B, Müller-Scholze S, Holle R, Thorand B, Koenig W, Wichmann HE, Kolb H; KORA Study Group.

    Gesundheitswesen. 2005 Aug;67 Suppl 1:S115-21.PMID: 16032528 [PubMed - indexed for MEDLINE]Related articles

    16.

    Sex differences in the associations of socioeconomic status with undiagnosed diabetes mellitus and impaired glucose tolerance in the elderly population: the KORA Survey 2000.

    Rathmann W, Haastert B, Icks A, Giani G, Holle R, Meisinger C, Mielck A; KORA Study Group.

    Eur J Public Health. 2005 Dec;15(6):627-33. Epub 2005 Jul 28.PMID: 16051657 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Differences in cardiovascular risk factors, insulin resistance, and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation: the Telde Study.

    Nóvoa FJ, Boronat M, Saavedra P, Díaz-Cremades JM, Varillas VF, La Roche F, Alberiche MP, Carrillo A.

    Diabetes Care. 2005 Oct;28(10):2388-93.PMID: 16186268 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance.

    Oberbach A, Tönjes A, Klöting N, Fasshauer M, Kratzsch J, Busse MW, Paschke R, Stumvoll M, Blüher M.

    Eur J Endocrinol. 2006 Apr;154(4):577-85.PMID: 16556721 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3.

    Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A; KORA Study Group.

    Diabetes Care. 2008 Mar;31(3):464-9. Epub 2007 Nov 26.PMID: 18039804 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.

    Herder C, Illig T, Baumert J, Müller M, Klopp N, Khuseyinova N, Meisinger C, Martin S, Thorand B, Koenig W.

    Atherosclerosis. 2008 Oct;200(2):380-8. Epub 2008 Feb 1.PMID: 18242614 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity